|
3176.0: Monday, November 8, 2004: 12:30 PM-2:00 PM | |||
Oral | |||
| |||
This session presents information concerning the detection of disease occurrence using pre-diagnosis data. Topics to be discussed include the development of a system to detect drug-resistant gonorrhea, and syndromic surveillance in rural health regions. Using syndromic surveillance systems to detect and measure occurrence of influenza will be discussed in the context of recent outbreaks, and in the context of the 1918 Influenza Pandemic. | |||
Learning Objectives: At the conclusion of the session, the participant (learner) in this session will be able to: 1. Describe a comparison of ED chief complaints for influenza and influenza-like illness (ILI) with preliminary ED diagnosis of influenza and ILI. 2. Describe the steps to detect Quinolone-resistant Neisseria gonorrhea by developing a surveillance system with partners including state epidemiologists and laboratorians, clinical laboratories, and private providers. 3. List the data sources and disease syndromes utilized for syndromic surveillance in the two northeast Tennessee public health regions. 4. Recognize the shifting age distribution of epidemic and pandemic influenza mortality. 5. Articulate the definition of influenza-like-illness as described by the CDC. | |||
Jon Mark Hirshon, MD, MPH | |||
Using Syndromic Surveillance to Monitor Influenza Occurrence in the District of Columbia Christine M. Yuan, MPH, LaVerne H. Jones, MPH, Samual C. Washington, MPH, John O. Davies-Cole, PhD, MPH, A. Chevelle Glymph, MPH | |||
Development of a surveillance system for Quinolone-resistant Neisseria gonorrhea in Michigan Carla Merritt, MPH, Kathryn E Macomber, MPH, Martha Boehme, MT (ASCP) | |||
Syndromic surveillance in two northeast Tennessee rural public health regions: Year one experiences Donna Garland Robbins, DrPH, MPH, Mark McCalman, MPH | |||
Characterizing the timing and impact of the 1918 influenza pandemic herald wave in New York City Donald Olson, MPH, Lone Simonsen, PhD, Paul Edelson, MD, Stephen S. Morse, PhD | |||
Development of a syndrome definition for influenza-like-illness Matthew J. Scholer, MD, PhD, Anna E Waller, ScD, Dennis Falls, BS, Kate Johnson, MHA, MSIS | |||
See individual abstracts for presenting author's disclosure statement and author's information. | |||
Organized by: | Epidemiology | ||
Endorsed by: | Statistics | ||
CE Credits: | CME, Health Education (CHES), Nursing |